SPRO - Spero Therapeutics, Inc.

QQQ $ 468.16 $ -5.41 (-1.13 %)

DIA $ 411.36 $ -1.55 (-0.38 %)

SPY $ 558.32 $ -3.26 (-0.58 %)

TLT $ 97.88 $ -0.12 (-0.12 %)

GLD $ 231.76 $ -1.64 (-0.7 %)

Previous Close

$ 1.37

Open

$ 1.36

Bid

$ 1.36 x 374

Ask

$ 1.37 x 200

Day's Range

$ 1.35 - $ 1.37

52 Week Range

$ 0.99 - $ 1.89

Volume

154,695

Average Volume

Market Cap

74.05M

Beta (5Y Monthly)

$ 0.92

PE Ratio (TTM)

$ 4.24

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2024	06-30-2024	10-Q
2	05-15-2024	03-31-2024	10-Q
3	03-13-2024	12-31-2023	10-K
4	11-13-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-30-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-10-2022	06-30-2022	10-Q
10	05-16-2022	03-31-2022	10-Q
11	03-31-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-11-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-08-2020	03-31-2020	10-Q
19	03-16-2020	12-31-2019	10-K
20	11-04-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	03-14-2019	12-31-2018	10-K
24	11-08-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	04-02-2018	12-31-2017	10-K
28	12-14-2017	09-30-2017	10-Q
29	11-05-2015	09-30-2015	10-Q
30	08-06-2015	06-30-2015	10-Q
31	05-05-2015	03-31-2015	10-Q
32	03-24-2015	12-31-2014	10-K
33	11-04-2014	09-30-2014	10-Q
34	08-07-2014	06-30-2014	10-Q
35	05-06-2014	03-31-2014	10-Q
36	03-25-2014	12-31-2013	10-K
37	11-07-2013	09-30-2013	10-Q
38	08-06-2013	06-30-2013	10-Q
39	05-07-2013	03-31-2013	10-Q
40	03-22-2013	12-31-2012	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

TD Cowen Upgrades Spero Therapeutics to Buy
08/06/2024 16:56:12

TD Cowen analyst Ritu Baral upgrades Spero Therapeutics (NASDAQ:SPRO) from Hold to Buy.

Cantor Fitzgerald Reiterates Overweight on...
08/06/2024 15:18:59

Cantor Fitzgerald analyst Louise Chen reiterates Spero Therapeutics (NASDAQ:SPRO) with a Overweight.

HC Wainwright & Co. Reiterates Buy on Sper...
08/06/2024 11:06:27

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $7 p...

Spero Therapeutics Q2 2024 GAAP EPS $(0.33...
08/05/2024 20:16:28

Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(...

HC Wainwright & Co. Reiterates Buy on Sper...
05/16/2024 10:55:06

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $7 p...

Spero Therapeutics Q1 2024 GAAP EPS $(0.24...
05/15/2024 20:31:55

Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of ...

Cantor Fitzgerald Reiterates Overweight on...
04/04/2024 13:45:57

Cantor Fitzgerald analyst Louise Chen reiterates Spero Therapeutics (NASDAQ:SPRO) with a Overweight.

HC Wainwright & Co. Reiterates Buy on Sper...
03/18/2024 11:02:31

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $7 p...

why-limbach-holdings-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why Limbach Holdings Shares Are Trading Lo...
03/14/2024 17:38:41

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarte...

Why Robinhood Shares Are Trading Higher By...
03/14/2024 12:05:43

Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported Februar...

Recap: Spero Therapeutics Q4 Earnings
03/13/2024 20:15:18

Spero Therapeutics Q4 2023 GAAP EPS $0.96 ...
03/13/2024 20:12:12

Spero Therapeutics (NASDAQ:SPRO) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For March 13, 2024
03/13/2024 10:15:56

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

Earnings Outlook For Spero Therapeutics
03/12/2024 17:01:27

Spero Therapeutics Announces Clearance Of ...
02/28/2024 13:08:36

Spero Therapeutics Expects To Provide Phas...
01/05/2024 13:11:53

Spero Therapeutics Announces First Patient...
01/02/2024 13:07:41

Spero Therapeutics, Inc. (NASDAQ:SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, develop...

5 Value Stocks In The Healthcare Sector
12/04/2023 14:44:10

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
11/14/2023 21:31:09

HC Wainwright & Co. Reiterates Buy on Sper...
11/14/2023 11:31:32

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $7 p...